Jill M. Erb

Inhibition of steroid 5.alpha.-reductase by unsaturated 3-carboxy steroids

Dennis A. Holt, Mark A. Levy, Hye Ja Oh et al. · Journal of Medicinal Chemistry · 1990 · 99 citations · Full text

Medicinal Chemistry, Enantioselective Synthesis, Human Enzyme +12

1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor

Peter Williams, Paul Anderson, Richard G. Ball et al. · Journal of Medicinal Chemistry · 1994 · 92 citations · Full text

Isolated Rat Uterus, Gynecology, Pharmacotherapy +16

Palladium-catalyzed phosphorylation of alkenyl triflates

Dennis A. Holt, Jill M. Erb · Tetrahedron Letters · 1989 · 84 citations

Engineering, Alkenyl Triflates, Organometallic Catalysis +2

Steroidal A ring aryl carboxylic acids: a new class of steroid 5.alpha.-reductase inhibitors

Dennis A. Holt, Mark A. Levy, David L. Ladd et al. · Journal of Medicinal Chemistry · 1990 · 69 citations · Full text

Bioorganic Chemistry, Chemoprevention Strategy, Aldo-keto Reductase +16

Development of Orally Active Oxytocin Antagonists:  Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[<i>d</i>][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Ian M. Bell, Jill M. Erb, Roger Freidinger et al. · Journal of Medicinal Chemistry · 1998 · 60 citations · Full text

Pharmacotherapy, Orally Active Oxytocin, Experimental Pharmacology +16